May 23, 2005
U.S. Sales Boost Reliv 1Q
Worldwidesales for Reliv International Inc. (NASDAQ:RELV) rose 23 percent to $29 millionin the first quarter. A sales growth of 26 percent in U.S. sales led the charge,with international markets contributing 4-percent sales growth. Reliv alsoreceived a boost from $1 million in sales of its new cardiovascular productlaunched during the quarter. As a result of all the sales gains, net incomeclimbed 25 percent to $2.1 million or $0.12 per share.
Management noted sales of both new and existing products havebeen strong, crediting the companys independent distributors. Relivsworldwide distributor count rose 14 percent compared to a year ago, and itsentrance into the German market has met with high distributor enthusiasm.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023